{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T17:59:47Z","timestamp":1783187987291,"version":"3.54.6"},"reference-count":23,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.3892\/br.2016.822","type":"journal-article","created":{"date-parts":[[2016,11,30]],"date-time":"2016-11-30T11:18:33Z","timestamp":1480504713000},"page":"79-82","source":"Crossref","is-referenced-by-count":3,"title":["Asymptomatic hyperCKemia during a two-year monitoring period: A case report and literature overview"],"prefix":"10.3892","volume":"6","author":[{"given":"Spyridon","family":"Klinis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Symeonidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Karanasios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanouil K.","family":"Symvoulakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2016,11,30]]},"reference":[{"key":"key20180107142843_b1-br-0-0-822","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/mus.880060203","article-title":"Serum creatine kinase isoenzymes: A review","volume":"6","author":"Nanji","year":"1983","journal-title":"Muscle Nerve"},{"key":"key20180107142843_b2-br-0-0-822","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/mus.23755","article-title":"Asymptomatic\/pauci-symptomatic creatine kinase elevations (hyperckemia)","volume":"47","author":"Silvestri","year":"2013","journal-title":"Muscle Nerve"},{"key":"key20180107142843_b3-br-0-0-822","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/ajcp\/79.5.582","article-title":"Heterogeneity of serum creatine kinase activity among racial and gender groups of the population","volume":"79","author":"Wong","year":"1983","journal-title":"Am J Clin Pathol"},{"key":"key20180107142843_b4-br-0-0-822","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1468-1331.2010.03012.x","article-title":"European Federation of Neurological Societies: EFNS guidelines on the diagnostic approach to pauci- or asymptomatic hyperCKemia","volume":"17","author":"Kyriakides","year":"2010","journal-title":"Eur J Neurol"},{"key":"key20180107142843_b5-br-0-0-822","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ahj.2007.06.008","article-title":"Distribution of creatine kinase in the general population: Implications for statin therapy","volume":"154","author":"Brewster","year":"2007","journal-title":"Am Heart J"},{"key":"key20180107142843_b6-br-0-0-822","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s004150200010","article-title":"Retrospective study of a large population of patients with asymptomatic or minimally symptomatic raised serum creatine kinase levels","volume":"249","author":"Prelle","year":"2002","journal-title":"J Neurol"},{"key":"key20180107142843_b7-br-0-0-822","doi-asserted-by":"crossref","first-page":"79","DOI":"10.59566\/IJBS.2009.5079","article-title":"Idiopathic Benign Hyper-CK-Emia","volume":"5","author":"Kaushik","year":"2009","journal-title":"Int J Biomed Sci"},{"key":"key20180107142843_b8-br-0-0-822","first-page":"3","volume-title":"Muscular dystrophy-advances and new trends","author":"Rowland","year":"1980"},{"key":"key20180107142843_b9-br-0-0-822","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/mus.20525","article-title":"Familial idiopathic hyper-CK-emia: An underrecognized condition","volume":"33","author":"Capasso","year":"2006","journal-title":"Muscle Nerve"},{"key":"key20180107142843_b10-br-0-0-822","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1600-0404.1988.tb06975.x","article-title":"Persistent hyperCKemia: Fourteen patients studied in retrospect","volume":"77","author":"Brewster","year":"1988","journal-title":"Acta Neurol Scand"},{"key":"key20180107142843_b11-br-0-0-822","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/(SICI)1097-4598(200004)23:4<575::AID-MUS17>3.0.CO;2-5","article-title":"Benign prognosis in idiopathic hyper-CK-emia","volume":"23","author":"Reijneveld","year":"2000","journal-title":"Muscle Nerve"},{"key":"key20180107142843_b12-br-0-0-822","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s00415-006-0223-y","article-title":"Follow-up of a large population of asymptomatic\/oligosymptomatic hyperckemic subjects","volume":"253","author":"D'Adda","year":"2006","journal-title":"J Neurol"},{"key":"key20180107142843_b13-br-0-0-822","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1212\/01.wnl.0000216144.69630.6e","article-title":"Diagnostic evaluation of clinically normal subjects with chronic hyperCKemia","volume":"66","author":"Fernandez","year":"2006","journal-title":"Neurology"},{"key":"key20180107142843_b14-br-0-0-822","first-page":"110","article-title":"Asymptomatic or minimally symptomatic hyperCKemia: Histopathologic correlates","volume":"8","author":"Dabby","year":"2006","journal-title":"Isr Med Assoc J"},{"key":"key20180107142843_b15-br-0-0-822","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/mus.880120308","article-title":"Asymptomatic hyper-CK-emia: An electrophysiologic and histopathologic study","volume":"12","author":"Joy","year":"1989","journal-title":"Muscle Nerve"},{"key":"key20180107142843_b16-br-0-0-822","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1213\/00000539-199705000-00016","article-title":"Malignant hyperthermia testing in patients with persistently increased serum creatine kinase levels","volume":"84","author":"Weglinski","year":"1997","journal-title":"Anesth Analg"},{"key":"key20180107142843_b17-br-0-0-822","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/088307389000500419","article-title":"Asymptomatic hyperCKemia: Detection of an isolated carrier of Duchenne muscular dystrophy","volume":"5","author":"Tachi","year":"1990","journal-title":"J Child Neurol"},{"key":"key20180107142843_b18-br-0-0-822","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.3892\/ol.2014.2385","article-title":"Value of caveolin-1 in cancer progression and prognosis: Emphasis on cancer-associated fibroblasts, human cancer cells and mechanism of caveolin-1 expression (Review)","volume":"8","author":"Chen","year":"2014","journal-title":"Oncol Lett"},{"key":"key20180107142843_b19-br-0-0-822","doi-asserted-by":"crossref","first-page":"15160","DOI":"10.1074\/jbc.271.25.15160","article-title":"Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins","volume":"271","author":"Song","year":"1996","journal-title":"J Biol Chem"},{"key":"key20180107142843_b20-br-0-0-822","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/ejhg.2009.103","article-title":"Caveolinopathies: From the biology of caveolin-3 to human diseases","volume":"18","author":"Gazzerro","year":"2010","journal-title":"Eur J Hum Genet"},{"key":"key20180107142843_b21-br-0-0-822","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1212\/WNL.54.6.1373","article-title":"Mutation in the CAV3 gene causes partial caveolin-3 deficiency and hyperCKemia","volume":"54","author":"Carbone","year":"2000","journal-title":"Neurology"},{"key":"key20180107142843_b22-br-0-0-822","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/mus.20593","article-title":"CAV3 gene mutation analysis in patients with idiopathic hyper-CK-emia","volume":"34","author":"Reijneveld","year":"2006","journal-title":"Muscle Nerve"},{"key":"key20180107142843_b23-br-0-0-822","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/jnnp.73.1.65","article-title":"Familial isolated hyperCKaemia associated with a new mutation in the caveolin-3 (CAV-3) gene","volume":"73","author":"Merlini","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Biomedical Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/br.2016.822\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T22:05:05Z","timestamp":1718921105000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/br.2016.822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,30]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,11,30]]},"published-print":{"date-parts":[[2017,1]]}},"alternative-id":["10.3892\/br.2016.822"],"URL":"https:\/\/doi.org\/10.3892\/br.2016.822","relation":{},"ISSN":["2049-9434","2049-9442"],"issn-type":[{"value":"2049-9434","type":"print"},{"value":"2049-9442","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,30]]}}}